OXFORD DRUG DESIGN LIMITED
OXFORD DRUG DESIGN LIMITED is a private limited company registered in the United Kingdom, under 04305857, incorporated on 17 October 2001. The company is currently active. Operates in the research and experimental development on biotechnology sector (SIC 72110). The company has been operating for 24 years. Registered office address: OX1 4EH Oxford, the United Kingdom. Formerly known as INHIBOX LIMITED. Directors include MS SARAH JANE HARGREAVES, DR BORIS AYZIKOVICH, and MR ROBERT GEORGE BOYLE, and 3 others. Associated with 6 related entities, including 04479349, OXFORD ANTIBIOTICS LIMITED, and 07488278. No sanctions, PEP status, or adverse risk signals are currently on record. Data sourced from UK Companies House.
Official Identifiers
Name Registry
INHIBOX LIMITED
Registered Address
OXFORD CENTRE FOR INNOVATION BLUE BOAR COURT
9 ALFRED STREET
OX1 4EH OXFORD
the United Kingdom
Signal Intelligence
No sanctions, PEP status, or adverse risk signals are currently on record for this entity.
Key Management & Controllers
Associated Companies
Associated Entities
Companies sharing one or more directors or officers with this entity.
Source Records (1)
| companieshouse | 04305857 | 2026-06-01 | open_in_new |